Trastuzumab upregulates expression of HLA-ABC and T cell costimulatory molecules through engagement of natural killer cells and stimulation of IFNγ secretion
出版年份 2015 全文链接
标题
Trastuzumab upregulates expression of HLA-ABC and T cell costimulatory molecules through engagement of natural killer cells and stimulation of IFNγ secretion
作者
关键词
-
出版物
OncoImmunology
Volume 5, Issue 4, Pages e1100790
出版商
Informa UK Limited
发表日期
2015-10-30
DOI
10.1080/2162402x.2015.1100790
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Engagement of immune effector cells by trastuzumab induces HER2/ERBB2 downregulation in cancer cells through STAT1 activation
- (2014) Yun Shi et al. BREAST CANCER RESEARCH
- Concurrent administration of trastuzumab with locoregional breast radiotherapy: long-term results of a prospective study
- (2014) J. Jacob et al. BREAST CANCER RESEARCH AND TREATMENT
- Investigating the positive relationship between tumor-infiltrating lymphocytes and trastuzumab therapy
- (2014) Peter Savas et al. Immunotherapy
- The MAPK Pathway Is a Predominant Regulator of HLA-A Expression in Esophageal and Gastric Cancer
- (2013) K. Mimura et al. JOURNAL OF IMMUNOLOGY
- Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy
- (2013) Sherene Loi OncoImmunology
- The anti-EGFR antibody cetuximab sensitizes human head and neck squamous cell carcinoma cells to radiation in part through inhibiting radiation-induced upregulation of HIF-1α
- (2012) Haiquan Lu et al. CANCER LETTERS
- Expression of MHC Class I on breast cancer cells correlates inversely with HER2 expression
- (2012) Masayuki Inoue et al. OncoImmunology
- T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survival
- (2011) S Ladoire et al. BRITISH JOURNAL OF CANCER
- Assembly and Initial Characterization of a Panel of 85 Genomically Validated Cell Lines from Diverse Head and Neck Tumor Sites
- (2011) M. Zhao et al. CLINICAL CANCER RESEARCH
- Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy
- (2011) J. Stagg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inverse correlation of HER2 with MHC class I expression on oesophageal squamous cell carcinoma
- (2010) T Maruyama et al. BRITISH JOURNAL OF CANCER
- The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity
- (2010) SaeGwang Park et al. CANCER CELL
- Recombinant Human Erythropoietin Antagonizes Trastuzumab Treatment of Breast Cancer Cells via Jak2-Mediated Src Activation and PTEN Inactivation
- (2010) Ke Liang et al. CANCER CELL
- T cell recognition of HLA-A2 restricted tumor antigens is impaired by the oncogene HER2
- (2010) Kousaku Mimura et al. INTERNATIONAL JOURNAL OF CANCER
- Correlation between NK function and response to trastuzumab in metastatic breast cancer patients
- (2008) Alessandra Beano et al. Journal of Translational Medicine
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search